Wincal Biopharm is a therapeutics development company located in the biotech hub of South San Francisco. Our team is devoted to developing Next-gen therapeutic options for vascular diseases such as age related macular degeneration (AMD), diabetic macular edema (DME), diabetic retinopathy (DR), subretinal fibrosis (SRF), geographic atrophy (GA) and uveal melanoma.